Varian Medical Systems China Co., Ltd.

Varian Medical Systems China Co., Ltd. specializes in linear accelerator systems, which are used for external beam radiotherapy. These devices are designed to deliver precise radiation therapy to treat cancer by targeting tumors with controlled doses of radiation. The company’s focus is on advanced oncology solutions, particularly in radiation oncology.

Varian Medical Systems China Co., Ltd. is based in the US, operating as a subsidiary of a US-based parent company. While the subsidiary handles local operations, manufacturing, and distribution in China, the core design, development, and regulatory oversight of its devices—such as the Halcyon linear accelerator—are aligned with the parent company’s global standards. This structure allows for localized support while maintaining consistency in product quality and compliance.

The devices produced by Varian Medical Systems China Co., Ltd., including linear accelerator systems like the Halcyon, are listed in the FDA’s Unique Device Identifier (UDI) database. This registry helps track and identify medical devices for regulatory, safety, and market surveillance purposes, ensuring transparency and traceability in the healthcare industry.

The devices manufactured by Varian Medical Systems China Co., Ltd., such as their linear accelerator systems, are classified as Class II under regulatory frameworks. This classification typically applies to devices that pose moderate risk and require special controls beyond general controls to ensure their safety and effectiveness. Class II devices undergo additional scrutiny to mitigate potential risks before authorization.